Alzheimer's and Parkinson's diseases are the most widespread forms of neurodegeneration in humans. Each year, 225,000 new cases of Alzheimer's disease are diagnosed in France, amounting to a total number of 900,000 patients in the country. This figure is expected to reach 2.1 million in 2040, representing a significant burden for public healthcare systems. So far, no efficient treatment options exist for such diseases.